Literature DB >> 11532692

Life satisfaction in renal transplant recipients: preliminary results from the transplant learning center.

D E Hricik1, R J Halbert, M L Barr, J H Helderman, A J Matas, J D Pirsch, F A Schenkel, B Siegal, R M Ferguson.   

Abstract

The Transplant Learning Center (TLC) was designed to improve quality of life (QOL) and preserve graft function in solid-organ transplant recipients. To meet the specific goals of the program, the Life Satisfaction Index and Transplant Care Index were designed to serve as composite measures for measuring transplant-specific QOL and the ability to care for a transplant, respectively. In this study, we analyzed self-reported health information to examine relationships between comorbidities and individual posttransplantation side effects, life satisfaction, and transplant care, defined by renal transplant recipients. Patients entered the TLC through self-referral or referral by a health professional. Included in the analysis were 3,676 TLC enrollees with a mean time since transplantation of 4.8 years. Comorbidities and adverse effects were common, with high blood pressure reported by 89% of respondents and unusual hair growth reported by 70%. Sexual dysfunction and headache had a greater impact on QOL than more common adverse effects, such as changes in body and facial shape, hirsutism, and tremor. Regression modeling was used to identify the most significant associations between QOL indices and structural (nonmedical), medical, and psychosocial factors. Greater life satisfaction was most strongly associated with being in control of one's health and living a normally active life with satisfying emotional relationships. Management of such clinical problems as adverse effects of medication and nonadherence should be informed by the patient's perspective. Clinicians should actively solicit information about physical activity, appearance concerns, side effects of medications, nonadherence, and sexual and relationship issues when evaluating renal transplant recipients.

Entities:  

Mesh:

Year:  2001        PMID: 11532692     DOI: 10.1053/ajkd.2001.26884

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  A mouse model of renal ischemia-reperfusion injury solely induced by cold ischemia.

Authors:  Jin Wei; Yingliang Wang; Jie Zhang; Lei Wang; Liying Fu; Byeong J Cha; Jacentha Buggs; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2019-07-10

Review 2.  Measuring patient-reported outcomes in solid organ transplant recipients: an overview of instruments developed to date.

Authors:  Irina Cleemput; Fabienne Dobbels
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Cross-sex transplantation alters gene expression and enhances inflammatory response in the transplanted kidneys.

Authors:  Lei Wang; Jiangping Song; Shaohui Wang; Jacentha Buggs; Rongjun Chen; Jie Zhang; Liqing Wang; Song Rong; Wenbin Li; Jin Wei; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-17

4.  Risk-adjusted analysis of relevant outcome drivers for patients after more than two kidney transplants.

Authors:  Lampros Kousoulas; Florian W R Vondran; Paulina Syryca; Juergen Klempnauer; Harald Schrem; Frank Lehner
Journal:  J Transplant       Date:  2015-02-01

5.  Erectile dysfunction pre and post kidney transplant recipients in Duhok city; cross sectional study.

Authors:  Shakir Saleem Jabali; Zana Sidiq M Saleem; Ayad Ahmad Mohammed; Newar M Mahmood
Journal:  Ann Med Surg (Lond)       Date:  2020-05-16

Review 6.  Health-related quality of life outcomes after kidney transplantation.

Authors:  Wolfgang Fiebiger; Christa Mitterbauer; Rainer Oberbauer
Journal:  Health Qual Life Outcomes       Date:  2004-01-08       Impact factor: 3.186

7.  Effects of an immunosuppressive treatment on the rat prostate.

Authors:  Marta Grabowska; Karolina Kędzierska; Katarzyna Michałek; Sylwia Słuczanowska-Głąbowska; Maciej Grabowski; Małgorzata Piasecka; Andrzej Kram; Iwona Rotter; Aleksandra Rył; Maria Laszczyńska
Journal:  Drug Des Devel Ther       Date:  2016-09-12       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.